• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kusaba Takuto  草場 拓人

ORCIDConnect your ORCID iD *help
Researcher Number 90847211
Other IDs
Affiliation (Current) 2025: 滋賀医科大学, 医学部, 非常勤講師
Affiliation (based on the past Project Information) *help 2024: 滋賀医科大学, 医学部, 非常勤講師
2021 – 2023: 滋賀医科大学, 医学部, 助教
Review Section/Research Field
Except Principal Investigator
Basic Section 56030:Urology-related
Keywords
Except Principal Investigator
γ-グルタミルシクロトランスフェラーゼ / siRNA / ドラッグデリバリーシステム / ホーミングペプチド / 前立腺癌 / 抗がん治療 / γーグルタミルシクロトランスフェラーゼ / がん / 抗癌療法 / グルタチオン
  • Research Projects

    (2 results)
  • Research Products

    (3 results)
  • Co-Researchers

    (9 People)
  •  腫瘍特異的ホーミングペプチド結合核酸によるGGCT標的抗癌治療の開発

    • Principal Investigator
      影山 進
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Shiga University of Medical Science
  •  Comprehensive analysis of glutathione-related molecular changes induced by inhibition of GGCT

    • Principal Investigator
      Kageyama Susumu
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Shiga University of Medical Science

All 2023 2022

All Journal Article Presentation

  • [Journal Article] Androgen receptor axis?targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer2022

    • Author(s)
      Wada Akinori、Narita Mitsuhiro、Nagasawa Masayuki、Kusaba Takuto、Kubota Shigehisa、Yoshida Tetsuya、Johnin Kazuyoshi、Kawauchi Akihiro、Kageyama Susumu
    • Journal Title

      Oncology Letters

      Volume: 24 Issue: 4 Pages: 333-333

    • DOI

      10.3892/ol.2022.13453

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09342, KAKENHI-PROJECT-20K09524
  • [Journal Article] Prognostic nutritional index of early post?pembrolizumab therapy predicts long?term survival in patients with advanced urothelial carcinoma2022

    • Author(s)
      Kageyama Susumu、Yoshida Tetsuya、Kobayashi Kenichi、Wada Akinori、Nagasawa Masayuki、Kubota Shigehisa、Kusaba Takuto、Jo Fumiyasu、Nakagawa Shota、Johnin Kazuyoshi、Narita Mitsuhiro、Kawauchi Akihiro
    • Journal Title

      Oncology Letters

      Volume: 25 Issue: 2 Pages: 49-49

    • DOI

      10.3892/ol.2022.13635

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09342
  • [Presentation] メタボローム解析を用いた泌尿器癌関連疲労バイオマーカーの探索2023

    • Author(s)
      沖中勇輝,片岡洋祐,草場拓人,窪田成寿,永澤誠之,和田晃典,小林憲市,吉田哲也,影山 進,河内明宏
    • Organizer
      第32回泌尿器科分子・細胞研究会
    • Data Source
      KAKENHI-PROJECT-21K09342
  • 1.  Kageyama Susumu (50378452)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 2.  吉田 哲也 (60510310)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 3.  窪田 成寿 (80759118)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 4.  富田 圭司 (30640148)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  茶野 徳宏 (40346028)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  河内 明宏 (90240952)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 7.  寺島 智也 (40378485)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  小林 憲市 (40727434)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  和田 晃典 (90750539)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi